European guidelines for personality disorders: past, present and future
Open accessAbstract
Personality disorders (PD) are common and burdensome mental disorders. The treatment of individuals with PD represents one of the more challenging areas in the field of mental health and health care providers need evidence-based recommendations to best support patients with PDs. Clinical guidelines serve this purpose and are formulated by expert consensus and/or systematic reviews of the current evidence. In this review, European guidelines for the treatment of PDs are summarized and evaluated. To date, eight countries in Europe have developed and published guidelines that differ in quality with regard to recency and completeness, transparency of methods, combination of expert knowledge with empirical data, and patient/service user involvement. Five of the guidelines are about Borderline personality disorder (BPD), one is about antisocial personality disorder and three concern PD in general. After evaluating the methodological quality of the nine European guidelines from eight countries, results in the domains of diagnosis, psychotherapy and pharmacological treatment of PD are discussed. Our comparison of guidelines reveals important contradictions between recommendations in relation to diagnosis, length and setting of treatment, as well as the use of pharmacological treatment. All the guidelines recommend psychotherapy as the treatment of first choice. Future guidelines should rigorously follow internationally accepted methodology and should more systematically include the views of patients and users.
AI snapshot
Written from the paper’s full text.
TL;DR
This review summarizes and evaluates European clinical guidelines for personality disorders, identifying nine guidelines from eight countries and comparing their recommendations on diagnosis, psychotherapy, and pharmacological treatment. It finds broad agreement that psychotherapy is first-choice treatment but important contradictions in diagnosis, treatment length/setting, and medication use, and calls for more rigorous, patient-inclusive future guidelines.
Key findings
- Nine European guidelines from eight countries were identified: five on borderline personality disorder (BPD), one on antisocial personality disorder (ASPD), and three on personality disorders in general.
- All guidelines recommend psychotherapy as the treatment of first choice; for BPD there is broad consensus that outpatient psychotherapy should be primary, but recommendations on length and setting conflict—e.g., Danish guidelines allow short-term (< 12 months) or long-term (≥ 12 months) psychotherapy, while British guidelines warn against brief interventions of less than 3 months, and Swiss recommendations describe outpatient psychotherapy 1–2 sessions per week over 1–3 years.
- Pharmacological treatment is generally not recommended as the primary intervention for PD; it is mainly for comorbid disorders or brief crisis use, though Swiss, Finnish, and Dutch guidelines suggest medication may target specific BPD dimensions such as anger, impulsivity, or negative mood, while British guidelines say not to use drug treatment specifically for BPD or its individual symptoms and limit crisis sedative use to no longer than 1 week.
- Diagnosis recommendations show some consensus on semi-structured interviews, but Swedish guidelines state such interviews alone are insufficient and recommend the LEAD principle, Danish guidelines do not recommend routine screening in primary care, Swiss guidelines recommend screening for specific symptoms and differential diagnoses, and only the Swiss guideline directly addresses severity.
Methods
- Narrative review/overview of European PD guidelines known to the authors, organized by geographical region and evaluated with attention to AGREE domains, especially rigour of development and applicability.
- Guidelines covered include Sweden (2017), Finland (2015), Denmark (2016), Germany (2009), the Netherlands (2008), the UK (2009 BPD and ASPD), Switzerland (2018), and Catalonia/Spain (2011); no Norwegian national clinical guidelines for PDs currently exist.
- The authors compared recommendations across three main areas—diagnosis, psychological treatment, and pharmacological treatment—using tables and qualitative synthesis; they did not perform formal AGREE scoring.
Limitations
- Stated: the authors acknowledge that using the AGREE system would have been a more systematic approach for guideline quality appraisal, but this was not considered feasible due to language barriers and the unfunded nature of the project; the AGREE manual recommends at least 2 and preferably 4 appraisers for reliable rating.
- Stated: existing guidelines vary in quality, recency, completeness, transparency of methods, combination of expert knowledge with empirical data, and patient/service user involvement; many recommendations are based on clinical/expert consensus or very low levels of evidence, and implementation and severity are generally neglected.
- Evident from the text: this is a narrative overview rather than a systematic review, with no formal quality scoring, and the guideline set is limited to those the authors were aware of, so language and awareness barriers may have excluded relevant European guidelines.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 31 cited sources checked · 0 supported · 0 flagged
- Findingown data
The Swedish guidelines do not include a method section outlining a systematic evaluation of the empirical support underlying different recommendations.
“They do not include a method section outlining a systematic evaluation of the empirical support underlying different recommendations, but rather rely heavily on guidelines from other countries”
Quote in the paperNot a substantial claim - Findingreasoning
The main limitation of the Swedish guidelines concerns the rigour of development, specifically that the path from evidence to recommendation is not always transparent and reproducible.
“From an evidence-based guidelines perspective, the main limitation concerns the rigour of development, more specifically that the path from evidence to recommendation is not always transparent and reproducible.”
Quote in the paperNot a substantial claim - Findingcitation
In Germany, treatment guidelines for personality disorders were first developed in 2009 by a committee of experts.
“Treatment guidelines for PD were first developed in 2009 by a committee of experts as delegated by a variety of professional societies and associations [15].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] DGPPN - Deutsche Gesellschaft für Psychiatrie, P.u.N.H., Behandlungsleitlinie Persönlichkeitsstörungen. Reihe: S2 Praxisleitlinien in Psychiatrie und Psychotherapie, Band 1. 2009.
Not checked in the free run.
- Findingcitation
A Standard of Care for patients with BPD was published in 2017.
“This perspective has now been covered in a standardized procedure of care for patients with BPD published in 2017 [18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Instituut, T, Zorgstandaard persoonlijkheidsstoornissen: Kwaliteitsontwikkeling GGZ [Care standard personality disorders: Quality development mental health care]. 2017.
Not checked in the free run.
- Findingown data
The first German guideline was at level S2.
“The first guideline was at level S2.”
Quote in the paperNot a substantial claim
- Findingreasoning
Due to the lack of efficacy studies, with the exception of BPD, recommendations in the 2009 German guideline for the treatment of personality disorder subtypes are based primarily on clinical expertise or published expert opinions.
“Due to the lack of efficacy studies, with the exception of BPD, recommendations in the 2009 guideline for the treatment of PD subtypes are based primarily on clinical expertise or published expert opinions.”
Quote in the paperNot a substantial claim - Findingown data
Eight countries in Europe have developed and published guidelines for the treatment of personality disorders.
“To date, eight countries in Europe have developed and published guidelines that differ in quality with regard to recency and completeness, transparency of methods, combination of expert knowledge with empirical data, and patient/service user involvement.”
Quote in the paperSubstantial claim - Findingcitation
In the Netherlands, the first Multidisciplinary Guideline for personality disorder was published in 2008.
“In the Netherlands, the first Multidisciplinary Guideline for PD was published in 2008 [17].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Committee DPMG. Dutch multidisciplinary guideline for personality disorders. Utrecht: Trimbos-institute; 2008.
Not checked in the free run.
- Findingnone given
All the guidelines recommend psychotherapy as the treatment of first choice.
“All the guidelines recommend psychotherapy as the treatment of first choice.”
Quote in the paperSubstantial claim - Findingown data
The comparison of guidelines reveals important contradictions between recommendations in relation to diagnosis, length and setting of treatment, as well as the use of pharmacological treatment.
“Our comparison of guidelines reveals important contradictions between recommendations in relation to diagnosis, length and setting of treatment, as well as the use of pharmacological treatment.”
Quote in the paperSubstantial claim - Findingcitation
The Swedish guidelines rely heavily on guidelines from other countries, e.g., NICE and the Australian Clinical Practice Guidelines.
“but rather rely heavily on guidelines from other countries, e.g., The National Institute for Health and Care Excellence [10] and the Australian Clinical Practice Guidelines [11].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10] Excellence, N.I.f.H.a.C., Borderline personality disorder: treatment and management (CG78). 2009.
Not checked in the free run.
- cites [11] Health, N. and M.R. Council, Clinical practice guideline for the management of borderline personality disorder. 2012, National Health and Medical Research Council Melbourne.
Not checked in the free run.
- Findingreasoning
The Finnish BPD guideline has been assessed according to the G-I-N guideline standards.
“The Finnish Medical Society Duodecim is one of the founding members of the Guidelines International Network (G-I-N), so the BPD guideline has been assessed according to the G-I-N guideline standards [13].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Qaseem A, et al. Guidelines international Network: toward international standards for clinical practice guidelines. Ann Intern Med. 2012;156(7):525–31. source
Not checked in the free run.
- Findingreasoning
The current revised Swedish clinical guidelines were developed based on existing research evidence.
“The current, revised clinical guidelines were developed based on existing research evidence.”
Quote in the paperNot a substantial claim - Findingown data
A majority of the guidelines reviewed lack a systematic process for capturing the views and values of patients and carers.
“A second limitation seen in the majority of the guidelines reviewed, is a lack of a systematic process for capturing the views and values of patients and carers.”
Quote in the paperSubstantial claim - Findingown data
Clinical guidelines for PD treatment focus almost exclusively on research on BPD.
“clinical guidelines for PD treatment focus almost exclusively on research on BPD”
Quote in the paperSubstantial claim - Findingnone given
Only the Swedish guideline recommends that while an evaluation of general criteria can be conducted in any part of the healthcare system, the diagnosis of a specific personality syndrome should only be made by specialist psychiatric services.
“Only the Swedish guideline recommends that while an evaluation of general criteria can be conducted in any part of the healthcare system, the diagnosis of a specific personality syndrome should only be made by specialist psychiatric services.”
Quote in the paperNot a substantial claim - Findingcitation
The number of RCTs has considerably increased since the development of the first BPD Guideline.
“the number of RCTs has considerably increased since the development of the first BPD Guideline [26]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Association, A.P., Practice guideline for the treatment of patients with borderline personality disorder. 2001: American Psychiatric Pub.
Not checked in the free run.
- Findingnone given
Few guidelines mention specific theoretical approaches such as MBT, DBT, TFP, or Schema Therapy.
“few guidelines mention specific theoretical approaches, such as Mentalization-Based Therapy (MBT), Dialectical Behaviour Therapy (DBT), Transference-focused Psychotherapy (TFP), or Schema Therapy”
Quote in the paperNot a substantial claim - Findingcitation
Despite criticism, the NICE guidelines have been highly influential.
“Despite criticism of some of the recommendations [20], the guidelines have been highly influential.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Omar H, Tejerina-Arreal M, Crawford MJ. Are recommendations for psychological treatment of borderline personality disorder in current UK guidelines justified? Systematic review and subgroup analysis. Personal Ment Health. 2014;8(3):228–37. source
Not checked in the free run.
- Findingcitation
Different domains of outcome are now looked at more thoroughly today than they were in the past.
“different domains of outcome are now looked at more thoroughly today than they were in the past”
Quote in the paperNot a substantial claim - Findingreasoning
Many of the current evidence-based treatments for BPD do not yet reach the condition of 'sufficient evidence'.
“many of the current evidence-based treatments for BPD do not yet reach the condition of “sufficient evidence””
Quote in the paperSubstantial claim - Findingcitation
The particular case of DBT compared to TAU may be the only exception to the lack of sufficient evidence.
“The particular case of DBT compared to TAU, may be the only exception [27].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Stoffers-Winterling JM, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012(8):1-255. source
Not checked in the free run.
- Findingown data
Issues pertaining to applicability and implementation were only addressed sparsely in the Spanish guideline.
“Issues pertaining to applicability and implementation were, similarly to other guidelines, only addressed sparsely.”
Quote in the paperNot a substantial claim - Findingown data
The implementation aspect of promoting evidence-based practices regarding PD treatments is seemingly neglected in existing guidelines.
“This crucial aspect of promoting evidence-based practices regarding PD treatments is seemingly neglected in existing guidelines, as we have shown.”
Quote in the paperSubstantial claim - Findingown data
With regard to recommendations for psychological treatment, the vast majority of evidence and recommendations pertains to BPD.
“With regard to recommendations for psychological treatment, it is noteworthy that the vast majority of evidence and recommendations pertains to BPD”
Quote in the paperNot a substantial claim - Findingcitation
The implementation of empirically-based treatments and its empirical documentation is lagging at least two decades behind the development and empirical validation of the treatments themselves.
“The implementation of empirically-based treatments and its empirical documentation is lagging at least two decades behind the development and empirical validation of the treatments themselves [29].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] McHugh RK, Barlow DH. The dissemination and implementation of evidence-based psychological treatments: a review of current efforts. Am Psychol. 2010;65(2):73. source
Not checked in the free run.
- Findingnone given
With the notable exception of the recent Swiss guideline, none of the guidelines address the issue of severity.
“With the notable exception of the recent Swiss guideline, none of the guidelines address the issue of severity.”
Quote in the paperNot a substantial claim - Findingnone given
Regarding diagnoses, there is some consensus on the use of semi-structured interviews.
“Regarding diagnoses (see Table 2), there is some consensus on the use of semi-structured interviews”
Quote in the paperNot a substantial claim - Findingnone given
There is no current evidence that any form of medication can modify the enduring features of personality.
“there is no current evidence that any form of medication can modify the enduring features of personality”
Quote in the paperSubstantial claim - Findingreasoning
There is a discrepancy in the guidelines' recommendations regarding medication.
“Another discrepancy in the guidelines´ recommendations can be found regarding medication.”
Quote in the paperSubstantial claim - Premisecitation
Guidelines using specific and active language lead to greater adherence than guidelines using vague or nonspecific phrasing.
“Guidelines using specific and active language have been shown to lead to greater adherence than guidelines using vague or nonspecific phrasing [8].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Grol R, et al. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. Bmj. 1998;317(7162):858–61. source
Not checked in the free run.
- Premisecitation
More severely disturbed patients might need longer treatments to improve.
“more severely disturbed patients might need longer treatments to improve [30]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] Tmej A, et al. Changes in attachment representation in psychotherapy: is reflective functioning the crucial factor? Z Psychosom Med Psychother. 2018;64(3):222–36.
Not checked in the free run.
- Premisecitation
A clinically derived stepwise model on how to apply different and more intense treatments for BPD patients with increasing severity has recently been published.
“a clinically derived stepwise model on how to apply different and more intense treatments for BPD patients with increasing severity has recently been published by [32]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Choi-Kain LW, Albert EB, Gunderson JG. Evidence-based treatments for borderline personality disorder: implementation, integration, and stepped care. Harvard Review of Psychiatry. 2016;24(5):342–56. source
Not checked in the free run.
- Premisecitation
Severity of PD is robustly associated with future risk of poor health and relationship difficulties.
“severity of PD is robustly associated with future risk of poor health and relationship difficulties [31]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Moran P, et al. The influence of personality disorder on the future mental health and social adjustment of young adults: a population-based, longitudinal cohort study. Lancet Psychiatry. 2016;3(7):636–45. source
Not checked in the free run.
- Premisecitation
A treatment that is effective in one domain does not necessarily confer effective treatment in another domain.
“a treatment that is effective in one domain does not necessarily confer effective treatment in another domain [26]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] Association, A.P., Practice guideline for the treatment of patients with borderline personality disorder. 2001: American Psychiatric Pub.
Not checked in the free run.
- Premisecitation
There is some evidence for positive effects of medication in the domains of mood stabilization and impulsivity.
“there is some evidence for positive effects of medication in the domains of mood stabilization and impulsivity [33]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Stoffers J, et al. Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev, 2010(6):1-324. source
Not checked in the free run.
- Classified as probably not a substantial claim. 57
- May combine two claims. 29
- The quote only partly states this claim. 1
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationThe Finnish Current Care Guidelines for BPD were developed by the Finnish Medical Society Duodecim in cooperation with the Finnish Psychiatric Association in 2015.
“The Finnish Current Care Guidelines for BPD were developed by the Finnish Medical Society Duodecim in cooperation with the Finnish Psychiatric Association in 2015 [12].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Association, F.M.S.D.a.t.F.P., Epävakaa persoonallisuus. Käypä hoito -suositus. [Borderline Personality Disorder. Current Care Guidelines]. 2015.
Not checked in the free run.
May combine two claims.
Findingnone givenFive of the guidelines are about Borderline personality disorder, one is about antisocial personality disorder, and three concern personality disorder in general.
“Five of the guidelines are about Borderline personality disorder (BPD), one is about antisocial personality disorder and three concern PD in general.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenIn the Finnish guideline, systematic method and evidence reviews were applied, but the recommendations can only partly be traced back to the supporting evidence.
“Systematic method and evidence reviews were applied in the development process, but the guideline recommendations can only partly be traced back to the supporting evidence.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationIn Denmark, the National Health Authority published guidelines for BPD in 2016.
“In Denmark, the National Health Authority published guidelines for BPD in 2016 [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Vind, AB, et al. National klinisk retningslinje for behandling af emotionel ustabil personlighedsstruktur, borderline type. 2015.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenIn the German guideline, a systematic search for evidence was conducted and the body of evidence is well described.
“A systematic search for evidence was conducted, and the body of evidence is well described.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenTen specific questions regarding screening in primary care, diagnosis, length of treatment, uni- or multimodality treatment, monitoring outcomes and pharmacological treatment formed the starting point for the Danish guideline.
“Ten specific questions with regards to screening in primary care, diagnosis, length of treatment, uni- or multimodality treatment, monitoring outcomes and pharmacological treatment formed the starting point for the development of the guideline.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningIn the Dutch guideline, the connection between evidence and strength of recommendations is not fully transparent and many recommendations were based on very low levels of evidence.
“However, the connection between evidence and strength of recommendations is not fully transparent and many recommendations were based on very low levels of evidence.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe Dutch guideline was developed by an expert workgroup and is based on scientific research critically and systematically appraised according to the level of evidence and completed with professional expertise.
“The guideline was developed by an expert workgroup and is based on the results of scientific research critically and systematically appraised according to the level of evidence and completed with professional expertise.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe Danish guideline used the GRADE system in developing recommendations.
“The GRADE system was used in developing the recommendations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenCurrently, there are no Norwegian national clinical guidelines for personality disorders.
“Currently, there are no Norwegian national clinical guidelines for PDs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone givenThe first systematically developed European guidelines on the management of personality disorders were published in 2008 and 2009 and came from Finland, Germany, the Netherlands and the UK.
“The first systematically developed European guidelines on the management of PDs were published in 2008 and 2009 and came from Finland, Germany, the Netherlands and the UK.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe Dutch guideline was developed to improve the treatment of individuals with personality disorders.
“The guideline was developed to improve the treatment of individuals with PDs.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThe earliest European guidelines identified derived from The Swedish Psychiatric Society, which developed Clinical guidelines for personality disorders in 2006, recently updated in 2017.
“The earliest European guidelines that we were able to identify derived from The Swedish Psychiatric Society. The Society developed Clinical guidelines for personality disorders in 2006, which were recently updated (2017) [9].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Ekselius L, et al. Personlighetssyndrom, kiniska riktlinjer för utredning och behandling. 2017: Gothia Förlag AB.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe Danish guideline's working process, methods and analyses behind the recommendations are publicly available on the National Health Authority website.
“The working process, methods and analyses behind the recommendations are publicly available on the National Health Authority website”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataThe nine European guidelines from eight countries differ in quality with regard to recency and completeness, transparency of methods, combination of expert knowledge with empirical data, and patient/service user involvement.
“To date, eight countries in Europe have developed and published guidelines that differ in quality with regard to recency and completeness, transparency of methods, combination of expert knowledge with empirical data, and patient/service user involvement.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenCurrently, an S3 guideline on BPD is in progress in Germany.
“Currently, an S3 guideline on BPD is in progress”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe major limitation of the Dutch guideline concerned implementation, especially in regard to systematically considering barriers and monitoring progress.
“The major limitation of the guideline concerned implementation, especially in regard to systematically considering barriers and monitoring progress.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone givenThe NICE guidelines cover many clinically important questions, but recommendations are often based on clinical/expert consensus rather than evidence.
“The guidelines cover many clinically important questions, but recommendations are often based on clinical/expert consensus rather than evidence.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe Swedish guidelines suggest adopting the LEAD principle as the gold standard.
“Instead, they suggest adopting the LEAD principle (Longitudinal Expert All Data) as the gold standard.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningScreening tools are addressed in three guidelines.
“Screening tools are addressed in three guidelines.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningThe Danish guidelines do not recommend the use of screening in primary care due to the high rate of false positives and negatives.
“while the Danish guidelines go even further in not recommending the use of screening in primary care due to the high rate of false positives and negatives.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe question of severity of the disorder is only directly addressed in the new Swiss guidelines, which state that it should be taken into consideration.
“The question of severity of the disorder is only directly addressed in the new Swiss guidelines, which state that it should be taken into consideration.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere is a considerable overlap between the different national guidelines, but also significant differences.
“we found a considerable overlap between the different national guidelines, there were also significant differences”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe German guideline specifically states that DBT has better empirical evidence than other types of specialized psychotherapy for BPD.
“the German guideline, which specifically state that DBT has better empirical evidence than other types of specialized psychotherapy for BPD”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationThe Spanish guideline was developed using the SIGN system.
“Methodologically, the guideline was developed using the system SIGN (Scottish Intercollegiate Guidelines Network) [22].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Network, S.I.G., R.T. Harbour, and L. Forsyth, SIGN 50: a guideline developer's handbook. 2008: Scottish Intercollegiate Guidelines Network.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenDanish guidelines include a practice-based recommendation of both short (<12 months) and long-term treatments.
“the Danish guidelines include a practice-based recommendation of both short (< 12 months) and long-term treatments”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationIn 2009, NICE published Guidelines on BPD and Antisocial Personality disorder.
“In 2009, the Guidelines on BPD [10] and Antisocial Personality disorder [19] were published.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10] Excellence, N.I.f.H.a.C., Borderline personality disorder: treatment and management (CG78). 2009.
Not checked in the free run.
- cites [19] Excellence, N.I.f.H.a.C., Antisocial personality disorder:prevention and management (Clinica guideline CG77). 2009.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationIn Switzerland, the Swiss Association for Psychiatry and Psychotherapy set up a task force that published recommendations for BPD in 2018.
“In Switzerland, the Swiss Association for Psychiatry and Psychotherapy set up a task force consisting of personality experts with the aim of coming up with practical and relevant clinical treatment recommendations for BPD rather than a new guideline. The task force published recommendations in 2018”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] Euler S, et al. Borderline-Störung: Behandlungsempfehlungen der SGPP. Psychiatr Psychother. 2018;169(5):135–43.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningThe Swiss recommendations were based on a consensus view giving weight to scientific evidence, good clinical practice and national applicability.
“Recommendations were based on a consensus view giving weight to scientific evidence, good clinical practice and national applicability.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Findingnone givenThere are both similarities and discrepancies across European guidelines.
“It is clear that there are both similarities and discrepancies across guidelines.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenThe emergence of new evidence has been monitored since 2009, but none of the emergent evidence has been deemed sufficiently strong to warrant changing the NICE guideline recommendations.
“The emergence of new evidence has been monitored since 2009, but none of the emergent evidence has been deemed sufficiently strong to warrant changing the guideline recommendations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based).
Findingnone givenExisting guidelines still have many limitations that need to be effectively tackled in future iterations.
“existing guidelines still have many limitations that need to be effectively tackled in future iterations”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingreasoningThese specific recommendations are not consistent and are somewhat at odds with the more general recommendation of being cautious with the use of medications.
“However, these specific recommendations are not consistent and are somewhat at odds with the more general recommendation of being cautious with the use of medications.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenIn the United Kingdom, NICE is an independent public body that provides national guidance and advice to improve health and social care.
“In the United Kingdom, National Institute of Health Care and Excellence (NICE) is an independent public body that provides national guidance and advice to improve health and social care in the United Kingdom”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
FindingreasoningRecommendations on pharmacological treatment are in overall agreement that medication should not be considered the primary intervention for PD, but should be used mainly for treating comorbid disorders and in some cases briefly during times of crisis.
“recommendations on pharmacological treatment are in overall agreement that, based on sparse trial evidence, medication should not be considered the primary intervention for PD, but should be used mainly for treating comorbid disorders and in some cases used briefly during times of crisis”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe Swiss recommendations are currently available in French and German.
“The recommendations are currently available in French and German.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe Swiss, Finnish and Dutch guidelines suggest that medication may be used to reduce specific dimensions of BPD such as anger, impulsivity or negative mood.
“The Swiss, Finnish and Dutch guidelines suggest that medication may be used to reduce specific dimensions of BPD such as anger, impulsivity or negative mood.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenThe Standard of Care was developed and formulated from the patient's perspective and the main goal of care was psychosocial recovery.
“This Standard of Care was developed and formulated from the patient’s perspective and the main goal of care was psychosocial recovery.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationBoth the British and German guidelines date back to 2009, with new relevant evidence having emerged since then.
“However, both guidelines date back to 2009, with new relevant evidence having emerged since then [23, 24].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [23] Bamelis LL, et al. Results of a multicenter randomized controlled trial of the clinical effectiveness of schema therapy for personality disorders. Am J Psychiatr. 2014;171(3):305–22. source
Not checked in the free run.
- cites [24] Weinbrecht A, et al. Avoidant personality disorder: a current review. Curr Psychiatry Rep. 2016;18(3):29. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningOn a general level, the consensus regarding the diagnosis of personality disorder is focused on which instruments to use and with what purpose and caveats.
“On a general level, the consensus regarding the diagnosis of PD is focused on which instruments to use and with what purpose and caveats.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThe Spanish guideline was developed by a team including a methodology consultant, psychiatrists, psychologists, a nurse and social workers, and was based on a systematic search and rating (AGREE and OSTEBA) of evidence.
“The guideline was developed by a team including a methodology consultant, psychiatrists, psychologists, a nurse and social workers, and was based on a systematic search and rating (AGREE and OSTEBA) of evidence.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThere are similarities in the broader field of recommended PD treatment, but also important differences, for example with respect to treatment of suicidal and self-harming behaviours.
“there are similarities in the broader field of recommended PD treatment, but also important differences, for example with respect to treatment of suicidal and self-harming behaviours”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe Spanish guideline is oriented towards specialists in mental health responsible for the treatment and care of individuals with BPD.
“The guideline is oriented towards specialists in mental health who are responsible for the treatment and care of individuals with BPD”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenIn Spain, a clinical practice guideline for BPD was developed in 2011 by the Catalan Agency for Health Information, Assessment and Quality.
“In Spain, a clinical practice guideline for BPD was developed in 2011 by the Catalan Agency for Health Information, Assessment and Quality.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningRecommendations on length of treatment and use of multiple modalities are not clear and are sometimes contradictory within and between guidelines.
“The recommendations in terms of both length of treatment and use of multiple modalities are not clear and are sometimes contradictory even within a guideline as well as between guidelines.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe Swedish guidelines specifically state that semi-structured interviews alone are not sufficient for diagnosis.
“although the Swedish guidelines specifically state that such interviews alone are not sufficient.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe German guidelines state that CBT has the strongest empirical support in the treatment of Avoidant PD.
“In addition, the German guidelines state that CBT has the strongest empirical support in the treatment of Avoidant PD (AvPD).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThis focus on BPD has not always been made explicit by the authors.
“although this has not always been made explicit by the authors”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenAccording to Google Scholar, the two NICE guidelines have been cited more than 250 times in the scientific literature.
“and according to Google Scholar, the two guidelines have thus far been cited more than 250 times in the scientific literature.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe only recommendations found for Antisocial Personality Disorder were cognitive-behavioural therapy (CBT), recommended by both the British and the German guidelines.
“The only recommendations we found for Antisocial Personality Disorder were cognitive-behavioural therapy (CBT), which was recommended by both the British and the German guidelines.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenFor BPD, there is broad consensus that outpatient psychotherapy should be the primary treatment.
“For BPD, there is broad consensus that outpatient psychotherapy should be the primary treatment.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe Swiss guidelines recommend the use of screening instruments to ascertain specific symptoms and differential diagnoses.
“Finally, the Swiss guidelines recommend the use of screening instruments to ascertain specific symptoms and differential diagnoses.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenThe Swiss guideline has strengths in addressing important clinical questions and considering national particularities but may be criticised for lack of transparency in using multiple levels of evidence without defining how this is reflected in the strength of recommendations.
“The guideline has several strengths in addressing important clinical questions and in considering national particularities but may be criticised in terms of a lack of transparency in using multiple levels of evidence without defining how this is reflected in the strength of recommendations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenBritish guidelines specifically warn against psychotherapy treatments lasting less than 3 months.
“the British guidelines specifically warn against the use of psychotherapy treatments lasting less than 3 months”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Findingnone givenOver the past decade, throughout Europe, a range of clinical guidelines for the management of PDs have emerged.
“Over the past decade, throughout Europe, a range of clinical guidelines for the management of PDs have emerged.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenInpatient treatment specifically adapted to BPD and day hospital treatment are also recommended.
“However, inpatient treatment specifically adapted to BPD and day hospital treatment are also recommended.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe Swedish guidelines warn against using screening for diagnostic purposes.
“The Swedish guidelines warn against using screening for diagnostic purposes”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenSome guidelines recommend the prescription of antipsychotic or antidepressant medication to target specific symptoms, while other guidelines insist on a general caution when it comes to psychopharmacological treatment.
“some guidelines recommend the prescription of antipsychotic or antidepressant medication to target specific symptoms, other guidelines insist on a general caution when it comes to psychopharmacological treatment”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Findingnone givenGuidelines for other PDs are either outdated or missing completely.
“guidelines for other PDs are either outdated or missing completely”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Findingnone givenThe issue of severity is generally neglected in existing guidelines.
“the issue of severity is generally neglected in existing guidelines”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGuideline quality can be assessed and quantified using the AGREE system across six domains.
“Guideline quality can be assessed and quantified using the AGREE system (Appraisal of Guidelines, Research and Evaluation), where a guideline is assessed across six domains [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Brouwers MC, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182(18):E839–42. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCompared to people without a personality disorder, individuals with personality disorder lead shorter lives and have significantly reduced quality of life.
“Compared to those without a PD, they lead shorter lives, and their quality of life is often significantly reduced [1, 2].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [1] Fok ML-Y, et al. Life expectancy at birth and all-cause mortality among people with personality disorder. J Psychosom Res. 2012;73(2):104–7. source
Not checked in the free run.
- cites [2] Cramer V, Torgersen S, Kringlen E. Personality disorders and quality of life. A population study. Compr Psychiatry. 2006;47(3):178–84. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGRADE provides guidance on how to link the body of evidence with the degree of strength of the recommendation.
“The Grade working group (www.gradeworkinggroup.org) provides guidance on how to link the body of evidence with the degree of strength of the recommendation (strong vs. weak/conditional).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGRADE emphasizes the importance of phrasing recommendations using active language and avoiding ambiguous or unclear wording.
“GRADE emphasizes the importance of phrasing recommendations using active language and of avoiding ambiguous or unclear wording, such as ‘if clinically appropriate’ or ‘if necessary’ [7].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] McDonald CJ, Overhage JM. Guidelines you can follow and can trust: an ideal and an example. Jama. 1994;271(11):872–3. source
Not checked in the free run.
May combine two claims.
PremisecitationA recent meta-analysis concluded that both DBT and psychodynamic approaches are effective for BPD symptoms.
“in a recent meta-analysis it was concluded that both DBT and psychodynamic approaches (the last category defined very broadly and including both MBT and brief therapy based on psychoanalytic principles) are effective for BPD symptoms [25].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Cristea IA, et al. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(4):319–28. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBecause of proficiency in English by most academics across Europe, the NICE guidelines have been used and referenced in all later European guidelines.
“Because of the proficiency in English by most academics across Europe, these guidelines have been used and referenced in all later European guidelines”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningA lack of diverse representation in the Swiss guideline development group may have limited the utility of these recommendations.
“However, a lack of diverse representation in the guideline development group may have limited the utility of these recommendations.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe differences identified between national guidelines are probably due, to a large extent, to the lack of methodological rigour with which guidelines have been developed along with the paucity of evidence for many of the clinical questions addressed by the guidelines.
“the differences we have identified are probably due to, to a large extent, the lack of methodological rigour with which guidelines have been developed along with the paucity of evidence for many of the clinical questions addressed by the guidelines”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe differences between national guidelines may in part reflect the different ages of the guidelines.
“These may in part reflect the different ages of the guidelines.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningGuidelines based on consensus are likely to have limited impact.
“This is a major limitation as guidelines based on consensus are likely to have limited impact.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningFor PDs in general, a five years criterion for guideline expiry might be too strict due to the slower accumulation of evidence.
“For PDs in general a five years criterion might be too strict due to the slower accumulation of evidence.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationThe AGREE manual recommends at least 2 appraisers and preferably 4 in order to achieve a reliable rating.
“the AGREE manual [6] recommends at least 2 appraisers and preferably 4 in order to achieve a reliable rating”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Brouwers MC, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182(18):E839–42. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningDue to language barriers and the unfunded nature of the project, use of the AGREE system was not considered feasible.
“due to language barriers and the unfunded nature of the project this was not considered feasible”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Recommendations in diagnosis and general treatment are independent of national health systems and thus generalizable to the whole of Europe.
“These areas were chosen because recommendations in diagnosis and general treatment should be independent of national health systems and thus be generalizable to the whole of Europe.”
The paper relies on this without support.
Widespread comorbidity is often seen in people with PDs, including several comorbid PDs and comorbidity with other clinical syndromes such as anxiety, depression, PTSD and substance use disorders.
“the widespread comorbidity often seen in people with PDs, not only in terms of several comorbid PDs, but also in terms of comorbidity with other clinical syndromes, such as anxiety, depression, post-traumatic stress disorder and substance use disorders”
The paper relies on this without support.
People with multiple disorders often receive too many or conflicting therapies.
“People with multiple disorders often receive too many or conflicting therapies”
The paper relies on this without support.
Guidelines should base their recommendations on an evidence-based paradigm.
“guidelines should base their recommendations on an evidence-based paradigm”
The paper relies on this without support.
Patients' needs and values are important sources of knowledge for clinical guidelines.
“Patients’ needs, and values are important sources of such knowledge”
The paper relies on this without support.
The strongest recommendations of guidelines stem from randomized controlled trials.
“their strongest recommendations stem from randomized controlled trials”
The paper relies on this without support.
DSM-5 and ICD-11 focus a great deal on severity in the diagnosis of PDs.
“The recently published DSM-5, with its Alternative Model for PDs as well as the upcoming ICD-11, focuses a great deal on severity in the diagnosis of PDs.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
National guidelines recommend one of the evidence-based psychotherapies mentioned above as first-line treatment for personality disorders.
“National guidelines (e.g. in Germany or the UK) recommend one of the evidence-based psychotherapies mentioned above as first-line treatment [30].”
From Euthanasia and assisted suicide in patients with personality disorders: a review of current practice and challenges (2020) · cites this paper as [30]
Today, a range of effective psychotherapeutic interventions are available for people with personality disorders in most of the countries that have so far legalized EAS.
“Today, a range of effective psychotherapeutic interventions are available for people with personality disorders in most of the countries that have so far legalized EAS.”
From Euthanasia and assisted suicide in patients with personality disorders: a review of current practice and challenges (2020) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Danish guideline has conflicting publication years
MinorThe text dates the Danish guideline to 2016, while the cited reference [14] dates it to 2015.
“In Denmark, the National Health Authority published guidelines for BPD in 2016 [14].”
“14. Vind AB National klinisk retningslinje for behandling af emotionel ustabil personlighedsstruktur, borderline type 2015”
British guideline also addresses severity
MinorThe paper says only the Swiss guideline addresses severity, but its table says the British guideline recommends routinely assessing the severity of antisocial personality disorder in forensic services.
“With the notable exception of the recent Swiss guideline, none of the guidelines address the issue of severity.”
“In forensic services, use measures such as PCL-R or PCL-SV to assess the severity of antisocial personality disorder as part of the routine assessment process.”
Cites
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,079 · see citing works
AGREE II: advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090449 · Cited by 3,790 · see citing works
Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines
Woolf, S. H., Grol, R. P. T. M., Hutchinson, A., Eccles, M., & Grimshaw, J. (1999) · BMJ · doi:10.1136/bmj.318.7182.527 · Cited by 2,549 · see citing works
McHugh, R. K., & Barlow, D. H. (2010) · American Psychologist · doi:10.1037/a0018121 · Cited by 909 · see citing works
Guidelines International Network: Toward International Standards for Clinical Practice Guidelines
Qaseem, A., Forland, F., Macbeth, F., Ollenschläger, G., Phillips, S., van der Wees, P., & for the Board of Trustees of the Guidelines International Network* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-7-201204030-00009 · Cited by 902 · see citing works
Psychological therapies for people with borderline personality disorder.
Stoffers-Winterling, J. M., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005652.pub2 · Cited by 895 · cited 1× · see citing works
“The particular case of DBT compared to TAU, may be the only exception [27].”
BackgroundGrol, R., Dalhuijsen, J., Thomas, S., Veld, C. I. ‘., Rutten, G., & Mokkink, H. (1998) · BMJ · doi:10.1136/bmj.317.7162.858 · Cited by 877 · see citing works
Institute of Medicine (1990) · National Academies Press eBooks · doi:10.17226/1626 · Cited by 807 · see citing works
Cristea, I. A., Gentili, C., Cotet, C. D., Palomba, D., Barbui, C., & Cuijpers, P. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.4287 · Cited by 655 · see citing works
Bamelis, L. L. M., Evers, S. M. A. A., Spinhoven, P., & Arntz, A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12040518 · Cited by 497 · see citing works
Pharmacological interventions for borderline personality disorder
Stoffers, J., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653.pub2 · Cited by 302 · see citing works
Life expectancy at birth and all-cause mortality among people with personality disorder
Fok, M. L.-Y., Hayes, R. D., Chang, C.-K., Stewart, R., Callard, F. J., & Moran, P. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.05.001 · Cited by 241 · see citing works
Self-citationWoolf, S. H., Schünemann, H. J., Eccles, M., Grimshaw, J., & Shekelle, P. (2012) · Implementation Science · doi:10.1186/1748-5908-7-61 · Cited by 236 · see citing works
Personality disorders and quality of life. A population study
Cramer, V., Torgersen, S., & Kringlen, E. (2006) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2005.06.002 · Cited by 177 · see citing works
Choi-Kain, L. W., Albert, E. B., & Gunderson, J. G. (2016) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000113 · Cited by 171 · see citing works
Moran, P., Romaniuk, H., Coffey, C., Chanen, A., Degenhardt, L., Borschmann, R., & Patton, G. C. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30029-3 · Cited by 124 · see citing works
Self-citationGuidelines You Can Follow and Can Trust: An Ideal and an Example
McDonald, C. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350082042 · Cited by 114 · see citing works
Avoidant Personality Disorder: a Current Review
Weinbrecht, A., Schulze, L., Boettcher, J., & Renneberg, B. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0665-6 · Cited by 110 · see citing works
Self-citationPharmacological interventions for people with borderline personality disorder
Stoffers-Winterling, J. M., Storebø, O. J., Vӧllm, B., Mattivi, J. T., Nielsen, S. S., Kielsholm, M. L., Faltinsen, E. G., Simonsen, E. H., & Lieb, K. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012956 · Cited by 18 · see citing works
Changes in Attachment Representation in Psychotherapy: Is Reflective Functioning the Crucial Factor?
Tmej, A., Fischer‐Kern, M., Doering, S., Alexopoulos, J., & Buchheim, A. (2018) · Zeitschrift für psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2018.64.3.222 · Cited by 18 · see citing works
Self-citationOmar, H., Tejerina-Arreal, M., & Crawford, M. J. (2014) · Personality and Mental Health · doi:10.1002/pmh.1264 · Cited by 15 · see citing works
Borderline-Störung: Behandlungsempfehlungen der SGPP
Euler, S., Dammann, G., Endtner, K., Leihener, F., Perroud, N. A., Reisch, T., Schmeck, K., Sollberger, D., Walter, M., & Kramer, U. (2018) · Swiss Archives of Neurology Psychiatry and Psychotherapy · doi:10.4414/sanp.2018.00598 · Cited by 13 · see citing works
Bourne, R. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.080440 · Cited by 12 · see citing works
DBT as a Suicide and Self-harm Treatment
Mehlum, L. I. (2017) · doi:10.1093/oxfordhb/9780198758723.013.44 · Cited by 4 · see citing works
Self-citationPersonlighetssyndrom, kiniska riktlinjer för utredning och behandling
Ekselius, L., Herlofson, J., Palmstierna, T., Perseius, K., & Rydén, G. (2017) · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Vind, AB, et al. National klinisk retningslinje for behandling af emotionel ustabil personlighedsstruktur, borderline type. 2015.
- Committee DPMG. Dutch multidisciplinary guideline for personality disorders. Utrecht: Trimbos-institute; 2008.
- Instituut, T, Zorgstandaard persoonlijkheidsstoornissen: Kwaliteitsontwikkeling GGZ [Care standard personality disorders: Quality development mental health care]. 2017.
Cited by
Sorted by citations
Psychotherapies for borderline personality disorder: a focused systematic review and meta-analysis
Stoffers-Winterling, J. M., Storebø, O. J., Kongerslev, M. T., Faltinsen, E., Todorovac, A., Sedoc Jørgensen, M., Sales, C. P., Edemann Callesen, H., Pereira Ribeiro, J., Völlm, B. A., et al. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.204 · Cited by 156 · see citing works
Bach, B., Kramer, U., Doering, S., di Giacomo, E., Hutsebaut, J., Kaera, A., Panfilis, C. D., Schmahl, C. G., Swales, M. A., Taubner, S., et al. (2022) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-022-00182-0 · Cited by 135 · see citing works
Self-citationGartlehner, G., Crotty, K., Kennedy, S. M., Edlund, M. J., Ali, R., Siddiqui, M., Fortman, R., Wines, R., Persad, E., & Viswanathan, M. (2021) · CNS Drugs · doi:10.1007/s40263-021-00855-4 · Cited by 126 · see citing works
Pharmacological interventions for people with borderline personality disorder
Stoffers-Winterling, J. M., Storebø, O. J., Ribeiro, J. P., Kongerslev, M., Vӧllm, B., Mattivi, J. T., Faltinsen, E. G., Todorovac, A., Jørgensen, M. S., Edemann-Callesen, H., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012956.pub2 · Cited by 118 · see citing works
A proposed severity classification of borderline symptoms using the borderline symptom list (BSL-23)
Kleindienst, N., Jungkunz, M., & Bohus, M. (2020) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-020-00126-6 · Cited by 107 · see citing works
Self-citationTrevillion, K., Stuart, R., Ocloo, J. E., Broeckelmann, E., Jeffreys, S., Jeynes, T., Allen, D., Russell, J., Billings, J., Crawford, M., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-021-03605-4 · Cited by 66 · see citing works
Self-citationStandard set of patient-reported outcomes for personality disorder
Rupel, V. P., Jagger, B., Fialho, L. S., Chadderton, L.-M., Gintner, T., Arntz, A., Baltzersen, Å.-L., Blazdell, J., Busschbach, J. J. V., Cencelli, M., et al. (2021) · Quality of Life Research · doi:10.1007/s11136-021-02870-w · Cited by 65 · see citing works
Self-citationPharmacological Management of Borderline Personality Disorder and Common Comorbidities
Pascual, J. C., Arias, L., & Soler, J. (2023) · CNS Drugs · doi:10.1007/s40263-023-01015-6 · Cited by 61 · see citing works
Mehlum, L., Schmahl, C., Berens, A., Doering, S., Hutsebaut, J., Kaera, A., Kramer, U., Moran, P. A., Renneberg, B., Ribaudi, J. S., et al. (2020) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-020-00131-9 · Cited by 42 · see citing works
Self-citationFuture Challenges in Psychotherapy Research for Personality Disorders
Kramer, U., Eubanks, C. F., Bertsch, K., Herpertz, S. C., McMain, S., Mehlum, L. I., Renneberg, B., & Zimmermann, J. (2022) · Current Psychiatry Reports · doi:10.1007/s11920-022-01379-4 · Cited by 41 · see citing works
Self-citationAssmann, N., Schaich, A., Arntz, A. R., Wagner, T., Herzog, P., Alvarez‐Fischer, D., Sipos, V., Jauch‐Chara, K., Klein, J. P., Hüppe, M., et al. (2024) · Psychotherapy and Psychosomatics · doi:10.1159/000538404 · Cited by 35 · see citing works
Gillett, G., Leeves, L., Patel, A., Prisecaru, A., Spain, D., & Happe, F. G. E. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221114603 · Cited by 32 · see citing works
Spong, A. J., Clare, I. C. H., Galante, J., Crawford, M. J., & Jones, P. B. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101937 · Cited by 31 · see citing works
Association of pharmacological treatments and real‐world outcomes in borderline personality disorder
Lieslehto, J., Tiihonen, J., Lähteenvuo, M., Mittendorfer‐Rutz, E., Tanskanen, A., & Taipale, H. T. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13564 · Cited by 30 · see citing works
Soler, J., Casellas‐Pujol, E., Fernández‐Felipe, I., Martín‐Blanco, A., Almenta, D., & Pascual, J. C. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13403 · Cited by 26 · see citing works
A Systematic Review of the Heterogeneity of Schema Therapy
van Dijk, S. D. M., Veenstra, M. S., van den Brink, R. H. S., van Alphen, S. P. J., & Voshaar, R. C. O. (2023) · Journal of Personality Disorders · doi:10.1521/pedi.2023.37.2.262 · Cited by 26 · see citing works
Nonremission After Electroconvulsive Therapy in Individuals With Major Depression
Hein, M., Mungo, A., & Loas, G. (2022) · Journal of Ect · doi:10.1097/yct.0000000000000857 · Cited by 25 · see citing works
Katakis, P., Schlief, M., Barnett, P., Rains, L. S., Rowe, S. L., Pilling, S., & Johnson, S. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04483-0 · Cited by 25 · see citing works
Proctor, J., Lawn, S., & McMahon, J. (2020) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12714 · Cited by 24 · see citing works
Ledden, S., Rains, L. S., Schlief, M., Barnett, P., Ching, B. C. F., Hallam, B., Günak, M. M., Steare, T., Parker, J., Labovitch, S., et al. (2021) · BMC Psychiatry · doi:10.1186/s12888-022-04171-z · Cited by 17 · see citing works
Stoffers-Winterling, J. M., Storebø, O. J., Simonsen, E., Jørgensen, M. S., Ribeiro, J. P., Kongerslev, M., & Lieb, K. (2022) · Psychology Research and Behavior Management · doi:10.2147/prbm.s342257 · Cited by 13 · see citing works
Storebø, O. J., Ribeiro, J. P., Kongerslev, M., Stoffers-Winterling, J. M., Jørgensen, M. S., Lieb, K., BATEMAN, A. W., Kirubakaran, R., Dérian, N., Karyotaki, E., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047416 · Cited by 21 · see citing works
Self-citationTroup, J., Taylor, B. L., Rains, L. S., Broeckelmann, E., Russell, J., Jeynes, T., Cooper, C., Steare, T., Dedat, Z., McNicholas, S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267787 · Cited by 21 · see citing works
Pascual, J. C., Martín‐Blanco, A., & Soler, J. (2021) · CNS Drugs · doi:10.1007/s40263-021-00852-7 · Cited by 21 · see citing works
Assmann, N., Jacob, G. A., Schaich, A., Berger, T., Zindler, T., Betz, L. T., Borgwardt, S., Arntz, A. R., Faßbinder, E., & Klein, J. P. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00063-x · Cited by 20 · see citing works
Amerio, A., Natale, A., Gnecco, G. B., Lechiara, A., Verrina, E., Bianchi, D., Fusar‐Poli, L., Costanza, A., Serafini, G., Amore, M., et al. (2023) · Medicina · doi:10.3390/medicina59050950 · Cited by 19 · see citing works
Laursen, S. L., Helweg-Jørgensen, S., Langergaard, A., Søndergaard, J., Sørensen, S. S., Mathiasen, K., Lichtenstein, M. B., & Ehlers, L. H. (2021) · Journal of Medical Internet Research · doi:10.2196/28874 · Cited by 19 · see citing works
Kaess, M., & Cavelti, M. (2025) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.70011 · Cited by 18 · see citing works
Banyard, H. G., Behn, A. J., & Delgadillo, J. (2021) · Cognitive Therapy and Research · doi:10.1007/s10608-021-10203-x · Cited by 18 · see citing works
Khasho, D., van Alphen, S. P. J., Ouwens, M. A., Arntz, A. R., Heijnen-Kohl, S., & Videler, A. C. (2023) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2900 · Cited by 16 · see citing works
Yuen, N. W. Z., Barnett, P., Rains, L. S., Johnson, S., & Billings, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0264239 · Cited by 15 · see citing works
Neues zur Diagnostik und Therapie von Persönlichkeitsstörungen – Änderungen in ICD‑11
Jeung-Maarse, H., & Herpertz, S. C. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00936-7 · Cited by 13 · see citing works
Adding EMDR for PTSD at the onset of treatment of borderline personality disorder: A pilot study
Wilhelmus, B., Marissen, M. A. E., van den Berg, D. P. G., Driessen, A., Deen, M. L., & Slotema, K. (2023) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2023.101834 · Cited by 12 · see citing works
Woodbridge, J., Townsend, M. L., Reis, S. L., & Grenyer, B. F. S. (2023) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-023-00219-y · Cited by 12 · see citing works
Juul, S., Frandsen, F. W., Bo, S., Sørensen, P. S., BATEMAN, A. W., & Simonsen, S. (2022) · Journal of Clinical Psychology · doi:10.1002/jclp.23378 · Cited by 12 · see citing works
Self-citationvan Schie, C. C., Lewis, K. L., Barr, K. R., Jewell, M., Malcolmson, N., Townsend, M. L., & Grenyer, B. F. S. (2024) · Personality and Mental Health · doi:10.1002/pmh.1609 · Cited by 12 · see citing works
Buglio, G. L., Boldrini, T., Polari, A. R., Fiorentino, F., Nelson, B., Solmi, M., Lingiardi, V., & Tanzilli, A. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1381864 · Cited by 11 · see citing works
Ribeiro, J. P., Juul, S., Kongerslev, M., Jørgensen, M. S., Vӧllm, B., Edemann-Callesen, H., Sales, C. P., Schaug, J. P., Lieb, K., Simonsen, E. H., et al. (2024) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.172 · Cited by 10 · see citing works
Hudon, A., Gaudreau-Ménard, C., Bouchard-Boivin, M., Godin, F., & Cailhol, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133685 · Cited by 10 · see citing works
Korsgaard, H. O., Ulberg, R., Hummelen, B., Midgley, N., Thorén, A., & Dahl, H. J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191710952 · Cited by 10 · see citing works
Cavelti, M., Seiffert, N., Lerch, S., Koenig, J., Reichl, C., & Kaess, M. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02222-8 · Cited by 10 · see citing works
Kujovic, M., Bahr, C., Riesbeck, M., Benz, D., Wingerter, L., Deiß, M., Margittai, Z., Reinermann, D., Plewnia, C., & Meisenzahl, E. M. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01901-0 · Cited by 10 · see citing works
Riemann, G., Chrispijn, M., Kupka, R., Penninx, B. W. J. H., & Giltay, E. J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.101 · Cited by 9 · see citing works
Bøe, A. S., Mehlum, L. I., Melle, I. S., & Qin, P. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.07.011 · Cited by 9 · see citing works
Self-citationLunghi, C., Cailhol, L., Massamba, V. K., Sidi, E. A. L., Sirois, C., Rahme, E., Rochette, L., Renaud, S., Villeneuve, É., Koch, M., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1243511 · Cited by 9 · see citing works
Developments in diagnosis and treatment of people with borderline personality disorder
Rao, S., Heidari, P., & Broadbear, J. H. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000625 · Cited by 9 · see citing works
Hein, M., Mungo, A., & Loas, G. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114650 · Cited by 9 · see citing works
Juul, S., Jakobsen, J., Hestbaek, E., Kamp, C., Olsen, M. H., Rishede, M., Frandsen, F., Bo, S., Poulsen, S., Sørensen, P., et al. (2025) · Psychotherapy and Psychosomatics · doi:10.1159/000544934 · Cited by 4 · see citing works
Self-citationKujovic, M., Benz, D., Riesbeck, M., Mollamehmetoglu, D., Becker-Sadzio, J., Margittai, Z., Bahr, C., & Meisenzahl, E. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-61795-9 · Cited by 8 · see citing works
Tomasetti, C., Autullo, G., Ballerini, A. C., de Bartolomeis, A., Dell’Osso, B. M., Fiorentini, A., Tonioni, F., Villari, V., & Berardis, D. D. (2024) · Annals of General Psychiatry · doi:10.1186/s12991-024-00507-z · Cited by 8 · see citing works
Hutsebaut, J. (2024) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.20230042 · Cited by 6 · see citing works
Polnay, A., McIntosh, L. G., Burnett, A., Williams, A., Cahill, C. M., Wilkinson, P. J., Mohammad, F., & Patrick, J. (2021) · Health Science Reports · doi:10.1002/hsr2.245 · Cited by 7 · see citing works
Bøe, A. S., Mehlum, L. I., Melle, I. S., & Qin, P. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13503 · Cited by 7 · see citing works
Self-citationGupta, N., Gupta, M., Madabushi, J. S., & Zubiar, F. (2023) · Cureus · doi:10.7759/cureus.40295 · Cited by 7 · see citing works
Bøe, A. S., Mehlum, L. I., Melle, I. S., & Qin, P. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.066 · Cited by 6 · see citing works
Self-citationMehlum, L. I. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13402 · Cited by 6 · see citing works
Self-citationNasonova, T. I., Romanov, D. V., Mukhametzyanova, A. K., Isaikin, A. I., & Parfenov, V. A. (2022) · Russian Journal of Pain · doi:10.17116/pain20222003121 · Cited by 5 · see citing works
Trust and Personality Disorders
Lis, S., Biermann, M., & Unoka, Z. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108770880.023 · Cited by 5 · see citing works
Esposito, C. M., Ceresa, A., Auxilia, A. M., Quarantini, F. Z., Caldiroli, A., Capuzzi, E., Clerici, M., & Buoli, M. (2022) · International Journal of Offender Therapy and Comparative Criminology · doi:10.1177/0306624x221139073 · Cited by 5 · see citing works
Pharmacological management of personality disorders: from evidence to practice
Völlm, B., & Cerci, D. (2025) · BJPsych Advances · doi:10.1192/bja.2024.30 · Cited by 4 · see citing works
Leone, F. D., Steingrímsson, S., Carlsen, H. K., Liljedahl, S. I., & Sand, P. K. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06716-4 · Cited by 4 · see citing works
Casellas‐Pujol, E., Soler, J., Schmidt, C., Soriano, J., & Pascual, J. C. (2024) · Personality and Mental Health · doi:10.1002/pmh.1614 · Cited by 4 · see citing works
Psychiatrists' Perspectives on Prescription Decisions for Patients With Personality Disorders
Sand, P. K., Dervisoski, E., Kollia, S., Strand, J., & Leone, F. D. (2024) · Journal of Personality Disorders · doi:10.1521/pedi.2024.38.3.225 · Cited by 4 · see citing works
Specialist teams as constituted are unsatisfactory for treating people with personality disorders
Duggan, C. F., & Tyrer, P. J. (2021) · BJPsych Bulletin · doi:10.1192/bjb.2021.69 · Cited by 4 · see citing works
Transference-Focused Psychotherapy (TFP) Informed Psychoeducation
Rentrop, M., Gerra, M. L., & Panfilis, C. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-68062-5_3 · Cited by 3 · see citing works
Louise, S., Dondzilo, L., Padmanabhan, V., & Pace, G. (2026) · Personality and Mental Health · doi:10.1002/pmh.70069 · Cited by 3 · see citing works
Rothman, B., Brewer, C., Chang, D., Hobart, M., Hefting, N., McQuade, R. D., & Grant, J. E. (2024) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.31 · Cited by 3 · see citing works
Recognition and management of auditory verbal hallucinations in borderline personality disorder
Niemantsverdriet, M. B. A., Slotema, C. W., Franken, I. H. A., Brandsma, J., Verbraak, M. J. P. M., Deen, M. L., Blom, J. D., & van der Gaag, M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1511280 · Cited by 3 · see citing works
Tong, K., Costello, S., McCabe, E., & Doherty, A. M. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02369-2 · Cited by 3 · see citing works
S3-Leitlinie Borderline-Persönlichkeitsstörung
Stoffers-Winterling, J. M., Taubner, S., Renneberg, B., & Lieb, K. (2023) · Die Psychotherapie · doi:10.1007/s00278-023-00685-3 · Cited by 3 · see citing works
Self-citationS3-Leitlinie Borderline-Persönlichkeitsstörung
Stoffers-Winterling, J. M., Taubner, S., Renneberg, B., & Lieb, K. (2023) · Der Nervenarzt · doi:10.1007/s00115-023-01566-5 · Cited by 3 · see citing works
Self-citationISSPD: Past, Present, and Future
Ronningstam, E. F., Simonsen, E. H., Chanen, A. M., Herpertz, S. C., Huprich, S. K., Newton‐Howes, G., Behn, A. J., Doering, S., Zanarini, M. C., Sharp, C., et al. (2021) · Journal of Personality Disorders · doi:10.1521/pedi.2021.35.1 · Cited by 3 · see citing works
Self-citationIgo, M., Yusa, Y., Ikeda, A., Shirahase, J., Sakamoto, W., Shinya, Y., & Ushijima, S. (2024) · International Journal of Mental Health · doi:10.1080/00207411.2023.2300567 · Cited by 2 · see citing works
Haeyen, S. (2025) · The Arts in Psychotherapy · doi:10.1016/j.aip.2025.102313 · Cited by 2 · see citing works
Multimodal approaches to the treatment of personality disorder
Tyrer, P., King, J., & Mulder, R. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2515066 · Cited by 2 · see citing works
Lunghi, C., Cailhol, L., Massamba, V. K., Renaud, S., David, P., Sidi, E. A. L., Biskin, R. S., Koch, M., Martineau, C., Rahme, E., et al. (2024) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-024-02768-1 · Cited by 2 · see citing works
Pickard, J. A., Finch, A. W., Huxley, E., Townsend, M. L., Deuchar, S., Lewis, K. L., Pratt, J., & Grenyer, B. F. S. (2021) · Trials · doi:10.1186/s13063-021-05327-0 · Cited by 2 · see citing works
Moran, P., Bick, D., Biddle, L., Borries, B., Kandiyali, R., Rigby, J., Seume, P., Sadhnani, V., Smith, N., Swales, M. A., et al. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-01177-y · Cited by 2 · see citing works
Self-citationPharmacotherapy of Personality Disorders
Baumann, P., & Herpertz, S. C. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_252-1 · Cited by 2 · see citing works
Pharmacotherapy of Personality Disorders
Baumann, P., & Herpertz, S. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_252 · Cited by 2 · see citing works
Tesli, M., Nesvåg, R., Haukvik, U. K., Gustavson, K., Tesli, N., Friestad, C., Skarðhamar, T., Næss, Ø., Czajkowski, N. O., Kendler, K. S., et al. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13596 · Cited by 2 · see citing works
Schmeck, K., & Romanos, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_20 · Cited by 2 · see citing works
Kim, E. S., & Lamb, Y. N. (2024) · Drugs & Therapy Perspectives · doi:10.1007/s40267-023-01042-9 · Cited by 1 · see citing works
Tiger, A., Molero, Y., Brikell, I., Chang, Z., Lichtenstein, P., Larsson, H., D'Onofrio, B. M., Hellner, C., Lagerberg, T., Jayaram‐Lindström, N., et al. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811251413479 · Cited by 1 · see citing works
Ulvestad, D. A., Ekberg, A., Bakali, J. V., Eikenæs, I. U.-M., Fjermestad‐Noll, J., Hjermann, E., Hummelen, B., Morken, K. T. E., Oftedal, E., Zahl, K., et al. (2026) · Psychotherapy Research · doi:10.1080/10503307.2026.2650154 · Cited by 1 · see citing works
Self-citationSalve, F. D., Rossi, C., Oasi, O., Malvini, L., Meliante, M., Percudani, M., & Messina, I. (2026) · Research in Psychotherapy Psychopathology Process and Outcome · doi:10.4081/ripppo.2026.893 · Cited by 1 · see citing works
Svensson, B., Bredtoft, J., Stenager, E., Larsen, P., Skøt, L., Sibbersen, C., & Mellentin, A. (2022) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2022.2067898 · Cited by 1 · see citing works
Bomhof, C., Löffler, J. P., Brugman, S., Lodder, P., van den End, A., van Dijk, M. K., van Westen, M., van Dam, L., Wielaard, I., Mensink, W., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07550-4 · Cited by 1 · see citing works
van Kaam, F. E., de Winter, R. F. P., ten Kate, C., Kop, R. S. H., Lelieveld, M., van Duursen, R., van Westen, M., van Harmelen, A., van Amelsvoort, T., & Weijers, J. G. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1685896 · Cited by 1 · see citing works
Williams, A. M. L., Beedie, S., Gumley, A., & Polnay, A. (2026) · Mental Health Review Journal · doi:10.1108/mhrj-04-2025-0039 · Cited by 1 · see citing works
White, C., St.Rose, S., Dwyer, J. B., Palmer, E. O. C., Yeow, J., Griffiths, K., Chee, B., Oyesanya, M., & Patel, R. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07974-6 · Cited by 1 · see citing works
Caldiroli, A., Tagliabue, I., Turco, M., Capuzzi, E., Fortunato, A., Tringali, A. G. M., Montana, C., Maggioni, L., Pellicioli, C., Sibilla, M., et al. (2022) · Psychology Health & Medicine · doi:10.1080/13548506.2022.2121971 · Cited by 1 · see citing works
Which factors are associated with duration of untreated illness in borderline personality disorder?
Esposito, C. M., Auxilia, A. M., Ceresa, A., Zanvit, F. G., Quarantini, F. Z., Capuzzi, E., Caldiroli, A., Clerici, M., & Buoli, M. (2023) · Early Intervention in Psychiatry · doi:10.1111/eip.13429 · Cited by 1 · see citing works
Bøe, J. V., Nissen‐Lie, H. A., & Wilberg, T. (2024) · Counselling Psychology Quarterly · doi:10.1080/09515070.2024.2394766 · Cited by 1 · see citing works
Self-citationYdrefelt, E., Björling, P., Freidlitz, J., & Sundström, N. (2025) · Oxford University Press eBooks · doi:10.1093/9780191964343.003.0025 · Cited by 1 · see citing works
Tratamiento farmacológico de los trastornos de la personalidad
Carrasco, J. L., & Pérez-Lombardo, M. (2019) · Revisiones en Psicofarmacolog�a · doi:10.24875/rpsic.m19000004 · Cited by 1 · see citing works
Fischer‐Kern, M., & Alexopoulos, J. (2020) · Psychotherapie Forum · doi:10.1007/s00729-020-00157-y · Cited by 1 · see citing works
Noroozi, M. O., & Zemestani, M. (2021) · Shenakht Journal of Psychology and Psychiatry · doi:10.32598/shenakht.8.2.51 · Cited by 1 · see citing works
Medikamente zur Behandlung von Persönlichkeits- und Verhaltensstörungen
Müller, M. J., & Benkert, O. (2020) · Springer eBooks · doi:10.1007/978-3-662-61753-3_11 · Cited by 1 · see citing works
Magnani, B., & Dimaggio, G. (2023) · QUADERNI DI PSICOTERAPIA COGNITIVA · doi:10.3280/qpc52-2023oa16176 · Cited by 1 · see citing works
- Authors
- Simonsen, S., Bateman, A., Bohus, M., Dalewijk, H. J., Doering, S., Kaera, A., Moran, P., Renneberg, B., Ribaudi, J. S., Taubner, S., Wilberg, T., & Mehlum, L.
- Affiliations
- University of Copenhagen (DK)
- Heidelberg University (DE)
- Medical University of Vienna (AT)
- Kanta-Hämeen Keskussairaala (FI)
- University of Bristol (GB)
- Freie Universität Berlin (DE)
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Corresponding author
- Simonsen, Sebastian
- ORCID
- Venue
- Borderline Personality Disorder and Emotion Dysregulation
- Published
- 2019-05-21
- Volume
- 6
- Issue
- 1
- Pages
- 9-9
- ISSN
- 2051-6673 (ISSN-L)
- PMC
- PMC6530178
- OpenAlex
- W2947641077
- Semantic Scholar
- 22c2b16c9d4a9752b9fd180695dba6300ad0d886
- Cited by
- 147
- References
- 26
- Citations by year
- 2026: 11 · 2025: 31 · 2024: 27 · 2023: 22 · 2022: 27 · 2021: 18 · 2020: 10 · 2019: 1
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Borderline Personality Disorder and Emotion Dysregulation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- heiDOK (Heidelberg University) (acceptedVersion, other-oa)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Explore Bristol Research (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Social Sciences › Psychology › Clinical Psychology › Personality Traits and Psychology
- Keywords
- personality disorders, borderline personality disorder, antisocial personality disorder, psychotherapy, pharmacotherapy, diagnosis, guideline methodological quality, European guidelines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review